RNAC Cartesian Therapeutics, Inc.
Nasdaq · SEC CIK 1453687 · EDGAR
- Bought, last 12 months
- $205.8K 1 purchases by 1 insiders
- Sold, last 12 months
- $258.7K 3 sales by 3 insiders
- Filings on record
- 182 since 2021-07-09, latest 2026-04-06 16:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BARABE TIMOTHY C | Dir | $205.8K | — |
| Brunn Carsten | Pres, CEO, Dir | — | $162.1K |
| Davis Blaine | CFO | — | $72.2K |
| Miljkovic Milos | Chief Medical Off | — | $24.4K |
| Bot Adrian Ion | Dir | — | — |
| Seymour June Ann | CAO | — | — |
| English Emily | Chief Ops Off | — | — |
| Hoge Elizabeth | 10% | — | — |
| Singer Michael | Dir | — | — |
| Kalayoglu Murat | Dir, 10% | — | — |
Transactions 169
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-04-06 16:28 | 2026-04-02 | RNAC | Hoge Elizabeth | 10% | M - OptEx | — | +758.0K | 5.31M | +17% | — |
| DI | 2026-04-06 16:28 | 2026-04-02 | RNAC | Kalayoglu Murat | 10% | M - OptEx | — | +758.0K | 5.31M | +17% | — |
| 2026-03-13 | 2026-03-13 | RNAC | Singer Michael | Dir | G - Gift | $0.00 | -6,555 | 49.6K | -12% | $0 | |
| 2026-01-08 | 2026-01-06 | RNAC | Davis Blaine | CFO | S - Sale | $6.82 | -10.6K | 121.2K | -8% | -$72.2K | |
| 2026-01-08 | 2026-01-06 | RNAC | Miljkovic Milos | Chief Medical Off | S - Sale | $6.82 | -3,573 | 58.8K | -6% | -$24.4K | |
| 2026-01-08 | 2026-01-06 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $6.82 | -23.8K | 323.5K | -7% | -$162.1K | |
| D | 2026-01-06 | 2026-01-02 | RNAC | Singer Michael | Dir | A - Grant | $0.00 | +2,600 | 56.1K | +5% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | ZENNER PATRICK J | Dir | A - Grant | $0.00 | +2,600 | 13.0K | +25% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | Miljkovic Milos | Chief Medical Off | A - Grant | $0.00 | +27.0K | 62.4K | +76% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | English Emily | Chief Ops Off | A - Grant | $0.00 | +24.0K | 94.2K | +34% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | BARABE TIMOTHY C | Dir | A - Grant | $0.00 | +2,600 | 57.0K | +5% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | Davis Blaine | CFO | A - Grant | $0.00 | +37.0K | 131.8K | +39% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $0.00 | +2,600 | 8.65M | +0.0% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | DeSilva Nishan M | Dir | A - Grant | $0.00 | +2,600 | 11.4K | +30% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | Malik Kemal | Dir | A - Grant | $0.00 | +2,600 | 11.1K | +30% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +143.2K | 347.3K | +70% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | Kalayoglu Murat | Dir, 10% | A - Grant | $0.00 | +2,600 | 511.6K | +0.5% | $0 |
| D | 2026-01-06 | 2026-01-02 | RNAC | Seymour June Ann | CAO | A - Grant | $0.00 | +6,500 | 6,500 | New | $0 |
| D | 2026-01-02 | 2025-12-30 | RNAC | English Emily | Chief Ops Off | M - OptEx | $3.30 | +7,500 | 70.2K | +12% | +$24.8K |
| D | 2025-12-18 | 2025-12-16 | RNAC | Bot Adrian Ion | Dir | A - Grant | $0.00 | +5,800 | 5,800 | New | $0 |
| 2025-12-08 | 2025-12-04 | RNAC | BARABE TIMOTHY C | Dir | P - Purchase | $6.86 | +30.0K | 54.4K | +123% | +$205.8K | |
| D | 2025-12-02 | 2025-11-28 | RNAC | English Emily | Chief Ops Off | M - OptEx | $3.30 | +7,500 | 62.7K | +14% | +$24.8K |
| 2025-11-19 | 2025-11-18 | RNAC | Singer Michael | Dir | G - Gift | $0.00 | -20.0K | 53.5K | -27% | $0 | |
| D | 2025-05-14 | 2025-05-12 | RNAC | English Emily | Chief Ops Off | M - OptEx | $3.30 | +7,500 | 55.2K | +16% | +$24.8K |
| D | 2025-04-16 | 2025-04-15 | RNAC | English Emily | Chief Ops Off | M - OptEx | $3.30 | +7,500 | 47.7K | +19% | +$24.8K |
| MI | 2025-04-11 | 2025-04-09+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $10.21 | +126.7K | 656.5K | +24% | +$1.29M |
| M | 2025-04-11 | 2025-04-09+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $10.21 | +22.4K | 8.63M | +0.3% | +$228.3K |
| M | 2025-03-20 | 2025-03-18+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $15.26 | +89.9K | 8.57M | +1% | +$1.37M |
| M | 2025-01-15 | 2025-01-13+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $17.47 | +21.0K | 8.53M | +0.2% | +$366.4K |
| D | 2025-01-13 | 2025-01-10 | RNAC | Jewell Christopher M | CSO | M - OptEx | $3.23 | +9,000 | 62.5K | +17% | +$29.1K |
| M | 2025-01-07 | 2025-01-03+ | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $16.78 | -17.3K | 204.1K | -8% | -$289.7K |
| M | 2025-01-07 | 2025-01-03+ | RNAC | Jewell Christopher M | CSO | S - Sale | $16.78 | -2,550 | 53.5K | -5% | -$42.8K |
| M | 2025-01-07 | 2025-01-03+ | RNAC | Davis Blaine | CFO | S - Sale | $16.78 | -7,989 | 98.8K | -7% | -$134.0K |
| M | 2025-01-07 | 2025-01-03+ | RNAC | Miljkovic Milos | Chief Medical Off | S - Sale | $16.78 | -1,880 | 35.4K | -5% | -$31.5K |
| M | 2025-01-07 | 2025-01-03+ | RNAC | English Emily | Chief Ops Off | S - Sale | $16.78 | -1,797 | 41.1K | -4% | -$30.1K |
| M | 2025-01-07 | 2025-01-03+ | RNAC | Kurtoglu Metin | CTO | S - Sale | $16.78 | -4,875 | 62.3K | -7% | -$81.8K |
| D | 2025-01-06 | 2025-01-02 | RNAC | English Emily | Chief Ops Off | A - Grant | $0.00 | +16.1K | 42.0K | +62% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $0.00 | +2,600 | 8.51M | +0.0% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Malik Kemal | Dir | A - Grant | $0.00 | +2,600 | 8,533 | +44% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | ZENNER PATRICK J | Dir | A - Grant | $0.00 | +2,600 | 10.4K | +33% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | BARABE TIMOTHY C | Dir | A - Grant | $0.00 | +2,600 | 24.4K | +12% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Singer Michael | Dir | A - Grant | $0.00 | +2,600 | 73.5K | +4% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | DeSilva Nishan M | Dir | A - Grant | $0.00 | +2,600 | 8,766 | +42% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Davis Blaine | CFO | A - Grant | $0.00 | +22.0K | 102.8K | +27% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Kurtoglu Metin | CTO | A - Grant | $0.00 | +16.1K | 67.1K | +32% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Miljkovic Milos | Chief Medical Off | A - Grant | $0.00 | +19.0K | 37.3K | +104% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | COX CARRIE SMITH | Dir | A - Grant | $0.00 | +2,600 | 15.6K | +20% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +57.5K | 221.4K | +35% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Kalayoglu Murat | Dir, 10% | A - Grant | $0.00 | +2,600 | 509.0K | +0.5% | $0 |
| D | 2025-01-06 | 2025-01-02 | RNAC | Jewell Christopher M | CSO | A - Grant | $0.00 | +16.1K | 56.0K | +40% | $0 |
| D | 2024-12-30 | 2024-12-26 | RNAC | English Emily | SVP, Head of Manufacturing | M - OptEx | $3.30 | +7,650 | 25.9K | +42% | +$25.2K |
| 2024-12-30 | 2024-12-26 | RNAC | Singer Michael | Dir | G - Gift | $0.00 | -20.0K | 70.9K | -22% | $0 | |
| M | 2024-12-23 | 2024-12-19+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $18.49 | +52.2K | 8.51M | +0.6% | +$965.0K |
| DM | 2024-12-11 | 2024-12-09+ | RNAC | Kurtoglu Metin | CTO | M - OptEx | $1.41 | +13.7K | 53.9K | +34% | +$19.3K |
| DM | 2024-12-11 | 2024-12-09+ | RNAC | Kurtoglu Metin | CTO | S - Sale+OE | $25.26 | -13.7K | 51.0K | -21% | -$345.1K |
| 2024-11-21 | 2024-11-19 | RNAC | Singer Michael | Dir | G - Gift | $0.00 | -28.8K | 90.9K | -24% | $0 | |
| DM | 2024-11-21 | 2024-11-19+ | RNAC | Kurtoglu Metin | CTO | S - Sale+OE | $16.78 | -38.7K | 51.0K | -43% | -$649.1K |
| DM | 2024-11-21 | 2024-11-19+ | RNAC | Kurtoglu Metin | CTO | M - OptEx | $1.41 | +38.7K | 51.2K | +308% | +$54.6K |
| D | 2024-11-21 | 2024-11-20 | RNAC | Jewell Christopher M | CSO | M - OptEx | $3.23 | +14.0K | 39.9K | +54% | +$45.2K |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Kurtoglu Metin | CTO | S - Sale+OE | $17.46 | -82.4K | 51.0K | -62% | -$1.44M |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Kurtoglu Metin | CTO | M - OptEx | $1.41 | +82.4K | 76.9K | New | +$116.1K |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Jewell Christopher M | CSO | M - OptEx | $3.23 | +52.1K | 42.0K | New | +$168.3K |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Jewell Christopher M | CSO | S - Sale+OE | $16.79 | -52.1K | 25.9K | -67% | -$875.0K |
| M | 2024-11-18 | 2024-11-14+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $17.07 | +431.9K | 8.46M | +5% | +$7.37M |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Miljkovic Milos | Chief Medical Off | S - Sale+OE | $16.50 | -55.0K | 18.3K | -75% | -$907.3K |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Miljkovic Milos | Chief Medical Off | M - OptEx | $3.23 | +55.0K | 38.3K | New | +$177.7K |
| DI | 2024-10-15 | 2024-10-11 | RNAC | Seven One Eight Three Four Irrevocable Trust | 10% | M - OptEx | — | +1.52M | 4.56M | +50% | — |
| DI | 2024-10-15 | 2024-10-11 | RNAC | Kalayoglu Murat | Dir, 10% | M - OptEx | — | +1.52M | 4.56M | +50% | — |
| DM | 2024-10-04 | 2024-10-02+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $20.87 | +205.7K | 7.86M | +3% | +$4.29M |
| DMI | 2024-10-04 | 2024-10-02 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | J - Other | — | -1.80M | 529.8K | -77% | — |
| D | 2024-10-04 | 2024-10-02 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | J - Other | — | +1.80M | 7.82M | +30% | — |
| M | 2024-09-27 | 2024-09-25 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | 0 | 6.02M | New | — |
| MI | 2024-09-27 | 2024-09-25 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | 0 | 12.8K | New | — |
| 2024-08-14 | 2024-08-12 | RNAC | BARABE TIMOTHY C | Dir | P - Purchase | $12.70 | +7,500 | 21.8K | +53% | +$95.2K | |
| I | 2024-08-14 | 2024-08-12 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $12.72 | +8,016 | 11.5K | +229% | +$102.0K |
| MI | 2024-07-05 | 2024-07-02 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $20.00 | +722.7K | 1,307 | New | +$14.45M |
| 2024-07-05 | 2024-07-02 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $20.00 | +1.64M | 1.64M | New | +$32.74M | |
| D | 2024-07-03 | 2024-07-01 | RNAC | Malik Kemal | Dir | A - Grant | $0.00 | +5,933 | 5,933 | New | $0 |
| DMI | 2024-04-10 | 2024-04-08 | RNAC | Seven One Eight Three Four Irrevocable Trust | 10% | C - Cnv Deriv | — | +3.42M | 3.04M | New | — |
| D | 2024-04-10 | 2024-04-08 | RNAC | Singer Michael | Dir | M - OptEx | — | +110.2K | 119.8K | +1,147% | — |
| DMI | 2024-04-10 | 2024-04-08 | RNAC | Singer Michael | Dir | M - OptEx | — | +643.6K | 383.8K | New | — |
| MI | 2024-04-10 | 2024-04-08 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | +801.4K | 0 | New | — |
| M | 2024-04-10 | 2024-04-08 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | +4.01M | 0 | New | — |
| D | 2024-04-10 | 2024-04-08 | RNAC | Kalayoglu Murat | Dir, 10% | M - OptEx | — | +491.9K | 506.4K | +3,386% | — |
| DI | 2024-04-10 | 2024-04-08 | RNAC | Kalayoglu Murat | Dir, 10% | M - OptEx | — | +2.93M | 3.04M | +2,658% | — |
| MI | 2024-03-28 | 2024-01-17+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $0.6202 | +18.4K | 97.6K | +23% | +$11.4K |
| DI | 2024-03-26 | 2024-03-26 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | $1.46 | +1.97M | 33.04M | +6% | +$2.88M |
| I | 2024-03-20 | 2024-03-18 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $0.6 | +19.0K | 31.07M | +0.1% | +$11.4K |
| MI | 2024-03-18 | 2024-03-14+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $0.5627 | +1.19M | 30.52M | +4% | +$667.2K |
| D | 2024-01-04 | 2024-01-02 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $0.00 | +178.0K | 7.47M | +2% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | ZENNER PATRICK J | Dir | A - Grant | $0.00 | +178.0K | 233.2K | +322% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Kurtoglu Metin | COO | A - Grant | $0.00 | +1.53M | 1.53M | New | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | COX CARRIE SMITH | Dir | A - Grant | $0.00 | +178.0K | 390.9K | +84% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | BARABE TIMOTHY C | Dir | A - Grant | $0.00 | +178.0K | 428.0K | +71% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +4.65M | 4.92M | +1,777% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Miljkovic Milos | Chief Medical Off | A - Grant | $0.00 | +548.2K | 548.2K | New | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Sallin Aymeric | Dir | A - Grant | $0.00 | +178.0K | 178.0K | New | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Kalayoglu Murat | Dir, 10% | A - Grant | $0.00 | +178.0K | 435.7K | +69% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | DeSilva Nishan M | Dir | A - Grant | $0.00 | +178.0K | 185.0K | +2,543% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Singer Michael | Dir, 10% | A - Grant | $0.00 | +178.0K | 288.1K | +162% | $0 |
Purchase Sale Sale after option exercise All abbreviations